Ecovyst Inc. (ECVT) stock
ECVTNYSEChemicals & Allied ProductsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 9/3053% above fair value
$10.97+0.22 (+2.05%)
Close on Nov 13, 2026Market cap $1.20BP/E 34.3Yield –
Earnings
Ecovyst's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Next report
Feb 25, 2027
Q4 FY2026 · estimated, before the open
Revenue, Q3 FY2026
$308.60M
+50.6% on a year earlier
Adjusted Diluted Income per share, Q3 FY2026
$0.23
$0.19 a year earlier
Latest guidance
Raised
Nov 5, 2026 · 8 items
Quarterly results
Revenue and earnings per share from each of Ecovyst's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Adj. EPS | Source |
|---|---|---|---|---|---|---|
| Q4 FY2026ended Dec 31, 2026 | Feb 25, 2027Expected | – | – | – | – | – |
| Q3 FY2026ended Sep 30, 2026 | Nov 5, 2026before the open | $308.60M | +50.6% | $0.17 | $0.23 | Release |
| Q2 FY2026ended Jun 30, 2026 | Aug 5, 2026before the open | $250.00M | +24.9% | $0.10 | $0.21 | Release |
| Q1 FY2026ended Mar 31, 2026 | May 5, 2026before the open | $215.00M | +32.6% | $0.04 | $0.11 | Release |
| Q4 FY2025ended Dec 31, 2025 | Feb 26, 2026before the open | $199.40M | +9.6% | $0.08 | $0.28 | Release |
| Q3 FY2025ended Sep 30, 2025 | Nov 4, 2025before the open | $204.90M | +14.3% | -$0.69 | $0.19 | Release |
| Q2 FY2025ended Jun 30, 2025 | Aug 7, 2025before the open | $200.10M | +9.5% | $0.05 | $0.12 | Release |
| Q1 FY2025ended Mar 31, 2025 | May 1, 2025before the open | $162.20M | +1.1% | -$0.03 | $0.01 | Release |
| Q4 FY2024ended Dec 31, 2024 | Feb 27, 2025before the open | $182.00M | +5.3% | -$0.26 | $0.28 | Release |
| Q3 FY2024ended Sep 30, 2024 | Oct 31, 2024before the open | $179.20M | +3.4% | $0.12 | $0.14 | Release |
| Q2 FY2024ended Jun 30, 2024 | Aug 1, 2024before the open | $182.80M | -0.7% | $0.07 | $0.12 | Release |
| Q1 FY2024ended Mar 31, 2024 | May 2, 2024before the open | $160.50M | -0.2% | $0.01 | $0.04 | Release |
| Q4 FY2023ended Dec 31, 2023 | Feb 28, 2024before the open | $172.80M | -5.5% | $0.26 | $0.22 | Release |
| Q3 FY2023ended Sep 30, 2023 | Nov 2, 2023before the open | $173.30M | -25.6% | $0.14 | $0.19 | Release |
| Q2 FY2023ended Jun 30, 2023 | Aug 3, 2023before the open | $184.10M | -18.2% | $0.22 | $0.29 | Release |
| Q1 FY2023ended Mar 31, 2023 | May 4, 2023before the open | $160.90M | -10.6% | -$0.01 | $0.06 | Release |
| Q4 FY2022ended Dec 31, 2022 | Feb 28, 2023before the open | $182.80M | +7.4% | $0.17 | $0.25 | Release |
| Q3 FY2022ended Sep 30, 2022 | Nov 1, 2022before the open | $233.00M | +39.2% | $0.16 | $0.23 | Release |
| Q2 FY2022ended Jun 30, 2022 | Jul 29, 2022before the open | $225.00M | – | $0.14 | $0.22 | Release |
| Q1 FY2022ended Mar 31, 2022 | Apr 28, 2022during market hours | $180.00M | – | $0.06 | $0.15 | Release |
| Q4 FY2021ended Dec 31, 2021 | Feb 25, 2022before the open | $170.20M | – | $0.06 | $0.17 | Release |
| Q3 FY2021ended Sep 30, 2021 | Nov 9, 2021before the open | $167.40M | – | $0.03 | $0.19 | Release |
| Q2 FY2021ended Jun 30, 2021 | Aug 5, 2021before the open | – | – | – | – | Release |
| Q1 FY2021ended Mar 31, 2021 | Apr 26, 2021during market hours | – | – | – | – | Filing |
| Q4 FY2020ended Dec 31, 2020 | Mar 9, 2021before the open | – | – | – | – | Filing |
| Q3 FY2020ended Sep 30, 2020 | Oct 30, 2020before the open | – | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
Ecovyst's latest outlook for periods it has not reported yet, compared with what it said before
| Metric | Period | Guidance | Before | Change | Given |
|---|---|---|---|---|---|
| SalesGAAP | FY2026 | $1.05B – $1.07B | – | New | Nov 5, 2026 |
| Sales | FY2026 | $1.02B – $1.06B | $890.00M – $970.00M | Raised | Aug 5, 2026 |
| Adjusted EBITDAnon-GAAP | FY2026 | $208.00M – $212.00M | – | New | Nov 5, 2026 |
| Adjusted EBITDAnon-GAAP | FY2026 | $195.00M – $207.00M | $180.00M – $195.00M | Raised | Aug 5, 2026 |
| Adjusted Diluted Income per sharenon-GAAP | FY2026 | $0.63 – $0.77 | – | New | Nov 5, 2026 |
| Adjusted Diluted Income per sharenon-GAAP | FY2026 | $0.58 – $0.72 | $0.50 – $0.65 | Raised | Aug 5, 2026 |
| Adjusted Free Cash Flownon-GAAP | FY2026 | $50.00M – $60.00M | – | New | Nov 5, 2026 |
| Adjusted Free Cash Flownon-GAAP | FY2026 | $45.00M – $55.00M | $40.00M – $55.00M | Raised | Aug 5, 2026 |
| Capital expendituresGAAP | FY2026 | $90.00M – $95.00M | – | New | Nov 5, 2026 |
| Capital expenditures | FY2026 | $85.00M – $95.00M | $80.00M – $90.00M | Raised | Aug 5, 2026 |
| Adjusted Net Incomenon-GAAP | FY2026 | $70.00M – $85.00M | – | New | Nov 5, 2026 |
| Adjusted Net Incomenon-GAAP | FY2026 | $65.00M – $85.00M | $55.00M – $75.00M | Raised | Aug 5, 2026 |
| Depreciation & AmortizationGAAP | FY2026 | $84.00M – $88.00M | – | Raised | Nov 5, 2026 |
| Depreciation & Amortization | FY2026 | $80.00M – $84.00M | $78.00M – $82.00M | Raised | Aug 5, 2026 |
| Interest expenseGAAP | FY2026 | $19.00M – $21.00M | – | New | Nov 5, 2026 |
| Interest expense | FY2026 | $18.00M – $22.00M | $18.00M – $22.00M | Lowered | Aug 5, 2026 |
Guidance vs results
The last range Ecovyst gave before each report, against the figure it then reported. Full years add up the four quarters.
| Period | Metric | Guidance | Actual | Result |
|---|---|---|---|---|
| FY2025 | Revenue | $700.00M – $740.00M | $766.60MΣ4Q | Above range |
| Q3 FY2024 | Adjusted Diluted Income per share | $0.12 – $0.18 | $0.14 | Within range |
Guidance history
Every forecast Ecovyst put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| Nov 5, 2026 | Capital expenditures | FY2026 | $90.00M – $95.00M | New |
| Nov 5, 2026 | Adjusted EBITDA | FY2026 | $208.00M – $212.00M | New |
| Nov 5, 2026 | Adjusted Diluted Income per share | FY2026 | $0.63 – $0.77 | New |
| Nov 5, 2026 | Adjusted Free Cash Flow | FY2026 | $50.00M – $60.00M | New |
| Nov 5, 2026 | Interest expense | FY2026 | $19.00M – $21.00M | New |
| Nov 5, 2026 | Depreciation & Amortization | FY2026 | $84.00M – $88.00M | Raised |
| Nov 5, 2026 | Adjusted Net Income | FY2026 | $70.00M – $85.00M | New |
| Nov 5, 2026 | Sales | FY2026 | $1.05B – $1.07B | New |
| Aug 5, 2026 | Capital expenditures | FY2026 | $85.00M – $95.00M | Raised |
| Aug 5, 2026 | Adjusted EBITDA | FY2026 | $195.00M – $207.00M | Raised |
| Aug 5, 2026 | Adjusted Diluted Income per share | FY2026 | $0.58 – $0.72 | Raised |
| Aug 5, 2026 | Adjusted Free Cash Flow | FY2026 | $45.00M – $55.00M | Raised |
| Aug 5, 2026 | Interest expense | FY2026 | $18.00M – $22.00M | Lowered |
| Aug 5, 2026 | Depreciation & Amortization | FY2026 | $80.00M – $84.00M | Raised |
| Aug 5, 2026 | Adjusted Net Income | FY2026 | $65.00M – $85.00M | Raised |
| Aug 5, 2026 | Sales | FY2026 | $1.02B – $1.06B | Raised |
| May 5, 2026 | Capital expenditures | FY2026 | $80.00M – $90.00M | Reaffirmed |
| May 5, 2026 | Adjusted EBITDA | FY2026 | $180.00M – $195.00M | Raised |
| May 5, 2026 | Adjusted Diluted Income per share | FY2026 | $0.50 – $0.65 | Raised |
| May 5, 2026 | Adjusted Free Cash Flow | FY2026 | $40.00M – $55.00M | Raised |
| May 5, 2026 | Interest expense | FY2026 | $18.00M – $22.00M | Lowered |
| May 5, 2026 | Depreciation & Amortization | FY2026 | $78.00M – $82.00M | Raised |
| May 5, 2026 | Adjusted Net Income | FY2026 | $55.00M – $75.00M | Reaffirmed |
| May 5, 2026 | Sales | FY2026 | $890.00M – $970.00M | Raised |
| Feb 26, 2026 | Capital expenditures | FY2026 | $80.00M – $90.00M | New |
| Feb 26, 2026 | Adjusted EBITDA | FY2026 | $175.00M – $195.00M | New |
| Feb 26, 2026 | Adjusted Diluted Income per share | FY2026 | $0.45 – $0.65 | New |
| Feb 26, 2026 | Adjusted Free Cash Flow | FY2026 | $35.00M – $55.00M | New |
| Feb 26, 2026 | Interest expense | FY2026 | $18.00M – $22.00M | New |
| Feb 26, 2026 | Depreciation & Amortization | FY2026 | $78.00M – $82.00M | Raised |
| Feb 26, 2026 | Adjusted Net Income | FY2026 | $55.00M – $75.00M | New |
| Feb 26, 2026 | Sales | FY2026 | $860.00M – $940.00M | New |
| Nov 4, 2025 | Capital expenditures of Ecoservices | FY2025 | $60.00M – $70.00M | New |
| Nov 4, 2025 | Adjusted EBITDA 2 from continuing operations | FY2025 | $170.00M | New |
| Nov 4, 2025 | Adjusted EBITDA 2 of Ecoservices | FY2025 | $200.00M | Raised |
| Nov 4, 2025 | Adjusted Free Cash Flow 2 | FY2025 | $75.00M – $85.00M | New |
| Nov 4, 2025 | Interest expense 3 | FY2025 | $32.00M – $34.00M | New |
| Nov 4, 2025 | Depreciation & Amortization | FY2025 | $75.00M – $80.00M | Raised |
| Nov 4, 2025 | Sales 1 of Ecoservices from continuing operations | FY2025 | $700.00M – $740.00M | New |
| Aug 7, 2025 | Capital expenditures | FY2025 | $80.00M – $90.00M | Reaffirmed |
| Aug 7, 2025 | Adjusted EBITDA | Q3 FY2025 | $62.00M – $72.00M | New |
| Aug 7, 2025 | Adjusted EBITDA | FY2025 | $242.00M – $254.00M | Narrowed |
| Aug 7, 2025 | Adjusted Diluted Income per share | FY2025 | $0.52 – $0.68 | Narrowed |
| Aug 7, 2025 | Adjusted Free Cash Flow | FY2025 | $70.00M – $80.00M | Raised |
| Aug 7, 2025 | Interest expense | FY2025 | $46.00M – $50.00M | Raised |
| Aug 7, 2025 | Depreciation & Amortization - Ecovyst | FY2025 | $92.00M – $98.00M | Raised |
| Aug 7, 2025 | Depreciation & Amortization - Zeolyst J.V. | FY2025 | $12.00M – $14.00M | Lowered |
| Aug 7, 2025 | Adjusted Net Income | FY2025 | $60.00M – $80.00M | Narrowed |
| Aug 7, 2025 | Sales | FY2025 | $795.00M – $835.00M | New |
| Aug 7, 2025 | Sales of 50% share of Zeolyst Joint Venture | FY2025 | $125.00M – $140.00M | Lowered |
| May 1, 2025 | Capital expenditures | FY2025 | $80.00M – $90.00M | New |
| May 1, 2025 | Adjusted EBITDA | Q2 FY2025 | $45.00M – $55.00M | New |
| May 1, 2025 | Adjusted EBITDA | FY2025 | $238.00M – $258.00M | Reaffirmed |
| May 1, 2025 | Adjusted Diluted Income per share | FY2025 | $0.50 – $0.70 | Reaffirmed |
| May 1, 2025 | Adjusted Free Cash Flow | FY2025 | $60.00M – $80.00M | Reaffirmed |
| May 1, 2025 | Interest expense | FY2025 | $47.00M – $53.00M | New |
| May 1, 2025 | Depreciation & Amortization - Ecovyst | FY2025 | $87.00M – $93.00M | Raised |
| May 1, 2025 | Depreciation & Amortization - Zeolyst J.V. | FY2025 | $12.00M – $14.00M | Lowered |
| May 1, 2025 | Sales for proportionate 50% share of Zeolyst Joint Venture | FY2025 | $115.00M – $130.00M | Raised |
| May 1, 2025 | Adjusted Net Income | FY2025 | $58.00M – $85.00M | Lowered |
| May 1, 2025 | Sales | FY2025 | $785.00M – $845.00M | Raised |
| Feb 27, 2025 | Capital expenditures | FY2025 | $80.00M – $90.00M | New |
| Feb 27, 2025 | Adjusted EBITDA | FY2025 | $238.00M – $258.00M | New |
| Feb 27, 2025 | Adjusted Diluted Income per share | FY2025 | $0.50 – $0.70 | New |
| Feb 27, 2025 | Adjusted Free Cash Flow | FY2025 | $60.00M – $80.00M | New |
| Feb 27, 2025 | Interest expense | FY2025 | $47.00M – $53.00M | New |
| Feb 27, 2025 | Depreciation & Amortization - Ecovyst | FY2025 | $87.00M – $93.00M | Raised |
| Feb 27, 2025 | Sales for proportionate 50% share of Zeolyst Joint Venture | FY2025 | $115.00M – $130.00M | New |
| Feb 27, 2025 | Depreciation & Amortization - Zeolyst J.V. | FY2025 | $12.00M – $14.00M | Lowered |
| Feb 27, 2025 | Adjusted Net Income | FY2025 | $58.00M – $85.00M | Raised |
| Feb 27, 2025 | Sales | FY2025 | $755.00M – $815.00M | New |
| Oct 31, 2024 | Capital expenditures | FY2024 | $70.00M – $80.00M | Reaffirmed |
| Oct 31, 2024 | Adjusted EBITDA | FY2024 | $230.00M – $245.00M | Reaffirmed |
| Oct 31, 2024 | Adjusted Diluted Income per share | FY2024 | $0.45 – $0.63 | Reaffirmed |
| Oct 31, 2024 | Free Cash Flow | FY2024 | $75.00M – $85.00M | Reaffirmed |
| Oct 31, 2024 | Adjusted Net Income | FY2024 | $53.00M – $74.00M | Lowered |
| Oct 31, 2024 | Depreciation & Amortization - Ecovyst | FY2024 | $88.00M – $92.00M | Raised |
| Oct 31, 2024 | Depreciation & Amortization - Zeolyst J.V. | FY2024 | $12.00M – $14.00M | Lowered |
| Oct 31, 2024 | Sales for proportionate 50% share of Zeolyst Joint Venture | FY2024 | $115.00M – $135.00M | Raised |
| Oct 31, 2024 | Interest expense | FY2024 | $48.00M – $52.00M | Raised |
| Oct 31, 2024 | Sales | FY2024 | $700.00M – $740.00M | Reaffirmed |
| Aug 1, 2024 | Capital expenditures | FY2024 | $70.00M – $80.00M | Reaffirmed |
| Aug 1, 2024 | Adjusted EBITDA | FY2024 | $230.00M – $245.00M | Lowered |
| Aug 1, 2024 | Adjusted EBITDA | Q3 FY2024 | $58.00M – $65.00M | New |
| Aug 1, 2024 | Adjusted Diluted Income per share | Q3 FY2024 | $0.12 – $0.18 | New |
| Aug 1, 2024 | Adjusted Diluted Income per share | FY2024 | $0.45 – $0.63 | New |
| Aug 1, 2024 | Free Cash Flow | FY2024 | $75.00M – $85.00M | Lowered |
| Aug 1, 2024 | Depreciation & Amortization - Zeolyst J.V. | FY2024 | $12.00M – $14.00M | Lowered |
| Aug 1, 2024 | Adjusted Net Income | Q3 FY2024 | $14.00M – $21.00M | New |
| Aug 1, 2024 | Interest expense | FY2024 | $48.00M – $52.00M | Raised |
| Aug 1, 2024 | Depreciation & Amortization - Ecovyst | FY2024 | $88.00M – $92.00M | Raised |
| Aug 1, 2024 | Sales for proportionate 50% share of Zeolyst Joint Venture | FY2024 | $115.00M – $135.00M | New |
| Aug 1, 2024 | Adjusted Net Income | FY2024 | $53.00M – $74.00M | Lowered |
| Aug 1, 2024 | Sales | FY2024 | $700.00M – $740.00M | Lowered |
| May 2, 2024 | Capital expenditures | FY2024 | $70.00M – $80.00M | New |
| May 2, 2024 | Adjusted EBITDA | FY2024 | $255.00M – $275.00M | Reaffirmed |
| May 2, 2024 | Free Cash Flow | FY2024 | $85.00M – $105.00M | Reaffirmed |
| May 2, 2024 | Depreciation & Amortization - Zeolyst J.V. | FY2024 | $12.00M – $14.00M | Reaffirmed |
| May 2, 2024 | Interest expense | FY2024 | $45.00M – $55.00M | New |
| May 2, 2024 | Depreciation & Amortization - Ecovyst | FY2024 | $85.00M – $95.00M | Raised |
| May 2, 2024 | Sales | FY2024 | $715.00M – $755.00M | Reaffirmed |
| May 2, 2024 | Sales for proportionate 50% share of Zeolyst Joint Venture | FY2024 | $145.00M – $165.00M | Reaffirmed |
| Feb 28, 2024 | Capital expenditures | FY2024 | $70.00M – $80.00M | New |
| Feb 28, 2024 | Adjusted EBITDA | FY2024 | $255.00M – $275.00M | New |
| Feb 28, 2024 | Adjusted Free Cash Flow | FY2024 | $85.00M – $105.00M | New |
| Feb 28, 2024 | Interest expense | FY2024 | $45.00M – $55.00M | New |
| Feb 28, 2024 | Depreciation & Amortization - Ecovyst | FY2024 | $85.00M – $95.00M | Raised |
| Feb 28, 2024 | Depreciation & Amortization - Zeolyst J.V. | FY2024 | $12.00M – $14.00M | Lowered |
| Feb 28, 2024 | Sales | FY2024 | $715.00M – $755.00M | New |
| Feb 28, 2024 | Sales for proportionate 50% share of Zeolyst Joint Venture | FY2024 | $145.00M – $165.00M | New |
| Nov 2, 2023 | Capital expenditures | FY2023 | $50.00M – $60.00M | New |
| Nov 2, 2023 | Adjusted EBITDA | FY2023 | $260.00M | Lowered |
| Nov 2, 2023 | Adjusted Free Cash Flow | FY2023 | $70.00M – $80.00M | Lowered |
| Nov 2, 2023 | Interest expense | FY2023 | $45.00M – $50.00M | New |
| Nov 2, 2023 | Depreciation & amortization - Ecovyst | FY2023 | $80.00M – $90.00M | Raised |
| Nov 2, 2023 | Depreciation & amortization - Zeolyst J.V. | FY2023 | $14.00M – $16.00M | Reaffirmed |
| Nov 2, 2023 | Sales | FY2023 | $675.00M – $705.00M | Lowered |
| Nov 2, 2023 | Sales for proportionate 50% share of Zeolyst Joint Venture | FY2023 | $150.00M – $160.00M | Lowered |
| Aug 3, 2023 | Capital expenditures | FY2023 | $50.00M – $60.00M | Lowered |
| Aug 3, 2023 | Adjusted EBITDA | FY2023 | $260.00M – $275.00M | Lowered |
| Aug 3, 2023 | Adjusted Free Cash Flow | FY2023 | $100.00M – $115.00M | Lowered |
| Aug 3, 2023 | Interest expense | FY2023 | $45.00M – $50.00M | Raised |
| Aug 3, 2023 | Depreciation & amortization - Ecovyst | FY2023 | $80.00M – $90.00M | Raised |
| Aug 3, 2023 | Depreciation & amortization - Zeolyst J.V. | FY2023 | $14.00M – $16.00M | Lowered |
| Aug 3, 2023 | Sales | FY2023 | $685.00M – $715.00M | Lowered |
| Aug 3, 2023 | Sales for proportionate 50% share of Zeolyst Joint Venture | FY2023 | $155.00M – $165.00M | Raised |
| May 4, 2023 | Capital expenditures | FY2023 | $60.00M – $70.00M | Reaffirmed |
| May 4, 2023 | Adjusted EBITDA | FY2023 | $285.00M – $300.00M | Reaffirmed |
| May 4, 2023 | Adjusted Free Cash Flow | FY2023 | $115.00M – $130.00M | Reaffirmed |
| May 4, 2023 | Interest expense | FY2023 | $45.00M – $50.00M | Lowered |
| May 4, 2023 | Depreciation & Amortization - Ecovyst | FY2023 | $80.00M – $90.00M | Raised |
| May 4, 2023 | Depreciation & Amortization - Zeolyst J.V. | FY2023 | $14.00M – $16.00M | Lowered |
| May 4, 2023 | Sales | FY2023 | $730.00M – $760.00M | Lowered |
| May 4, 2023 | Sales for proportionate 50% share of Zeolyst Joint Venture | FY2023 | $145.00M – $155.00M | New |
| Feb 28, 2023 | Capital expenditures | FY2023 | $60.00M – $70.00M | New |
| Feb 28, 2023 | Adjusted EBITDA | FY2023 | $285.00M – $300.00M | New |
| Feb 28, 2023 | Adjusted Free Cash Flow | FY2023 | $115.00M – $130.00M | New |
| Feb 28, 2023 | Interest expense | FY2023 | $45.00M – $50.00M | New |
| Feb 28, 2023 | Depreciation & Amortization - Ecovyst | FY2023 | $80.00M – $90.00M | Raised |
| Feb 28, 2023 | Sales for proportionate 50% share of Zeolyst Joint Venture | FY2023 | $145.00M – $155.00M | New |
| Feb 28, 2023 | Depreciation & Amortization - Zeolyst J.V. | FY2023 | $14.00M – $16.00M | Lowered |
| Feb 28, 2023 | Sales | FY2023 | $760.00M – $790.00M | New |
| Nov 1, 2022 | Capital Expenditures | FY2022 | $55.00M – $65.00M | Reaffirmed |
| Nov 1, 2022 | Adjusted EBITDA | FY2022 | $265.00M – $275.00M | Reaffirmed |
| Nov 1, 2022 | Adjusted Free Cash Flow | FY2022 | $115.00M – $125.00M | Reaffirmed |
| Nov 1, 2022 | Sales | FY2022 | $810.00M – $830.00M | Lowered |
| Nov 1, 2022 | Sales for proportionate 50% share of Zeolyst Joint Venture | FY2022 | $135.00M – $145.00M | Reaffirmed |
| Jul 29, 2022 | Capital Expenditures | FY2022 | $55.00M – $65.00M | New |
| Jul 29, 2022 | Adjusted EBITDA | FY2022 | $265.00M – $275.00M | Raised |
| Jul 29, 2022 | Adjusted Free Cash Flow | FY2022 | $115.00M – $125.00M | Reaffirmed |
| Jul 29, 2022 | Sales | FY2022 | $830.00M – $850.00M | Raised |
| Jul 29, 2022 | Sales | FY2022 | $135.00M – $145.00M | Lowered |
| Apr 28, 2022 | Capital Expenditures | FY2022 | $55.00M – $65.00M | New |
| Apr 28, 2022 | Adjusted EBITDA | FY2022 | $260.00M – $270.00M | Reaffirmed |
| Apr 28, 2022 | Adjusted Free Cash Flow | FY2022 | $115.00M – $125.00M | Reaffirmed |
| Apr 28, 2022 | Sales | FY2022 | $810.00M – $830.00M | Raised |
| Apr 28, 2022 | Sales for proportionate 50% share of Zeolyst Joint Venture | FY2022 | $150.00M – $160.00M | New |
| Feb 25, 2022 | Adjusted EBITDA | FY2022 | $260.00M – $270.00M | New |
| Feb 25, 2022 | Adjusted Free Cash Flow | FY2022 | $115.00M – $125.00M | New |
| Feb 25, 2022 | Sales | FY2022 | $730.00M – $750.00M | New |
| Nov 9, 2021 | Adjusted EBITDA | FY2021 | $220.00M – $225.00M | New |
| Nov 9, 2021 | Adjusted free cash flow | FY2021 | $70.00M – $80.00M | New |
| Nov 9, 2021 | Sales | FY2021 | $590.00M – $600.00M | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases Ecovyst filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Update
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Update
- Results
See a number that looks wrong?